Monteiro Luís, Macedo Ana, Corte-Real Luis, Salazar Filomena, Pacheco José-Júlio
Oral Surgery and Oral Medicine Department, University Institute of Health Sciences, CESPU, Paredes 4585-116, Portugal.
Cancer Research Group - IINFACTS, University Institute of Health Sciences, CESPU, Paredes 4585-116, Portugal.
J Clin Exp Dent. 2020 Jun 1;12(6):e561-e567. doi: 10.4317/jced.56953. eCollection 2020 Jun.
Snoring disorder is a common problem among world population. Treatment modalities may involve surgical and non-surgical procedures. As main objective we proposed to evaluate the efficacy of non-ablative Er:YAG laser in the treatment of snoring disorder.
We performed an interventional study in 30 patients with snoring disorders. Three sessions were performed with Er:YAG laser 2940nm in long pulse mode (2J/cm2) and smooth mode (10-8J/cm2) in oropharynx region. We analyzed the efficacy of this protocol using questionnaires for snoring intensity, snoring related characteristics of quality of life (including the Epworth sleepness scale and OHIP-14), the satisfaction of the patients and existence of adverse effects comparing the results before and after the treatment using Wilcoxon Signed Rank test.
There was a 96.7% satisfaction rate after one month of treatment, and 96.4% after 6 months. A reduction of the severity of snoring from 8±1.9 before the treatment to 1.6±1.1 one month after treatment was observed (<0.001). Decrease in mean values of Epworth sleepness scale (9.97±5.3 to 6.54±4.3) (=0.002), and OHIP-14 score (10.9±6.2 to 5.9±5) (<0.001) were also noted. A significant decrease in the Mallampatti and Friedman classification scores were observed (=0.001 and <0.001, respectively). No anesthesia was required, nor adverse effects were observed.
Non-ablative Er:YAG laser treatment is a safe, painless, and can be an effective treatment option to reduce snoring and is well accepted by the patient. However, further controlled studies with longer follow-up are required. Er:YAG laser, snoring, sleep disorders, epworth sleepiness scale, OHIP-14.
打鼾障碍是全球人口中的常见问题。治疗方式可能包括手术和非手术程序。作为主要目标,我们旨在评估非消融性铒激光治疗打鼾障碍的疗效。
我们对30例打鼾障碍患者进行了一项干预性研究。在口咽区域使用波长为2940nm的铒激光以长脉冲模式(2J/cm²)和平滑模式(10 - 8J/cm²)进行了三次治疗。我们使用关于打鼾强度、打鼾相关生活质量特征(包括爱泼华嗜睡量表和OHIP - 14)的问卷分析该方案的疗效,通过威尔科克森符号秩检验比较治疗前后患者的满意度及不良反应的存在情况。
治疗1个月后满意度为96.7%,6个月后为96.4%。观察到打鼾严重程度从治疗前的8±1.9降至治疗1个月后的1.6±1.1(<0.001)。爱泼华嗜睡量表的平均值也有所下降(从9.97±5.3降至6.54±4.3)(=0.002)以及OHIP - 14评分(从10.9±6.2降至5.9±5)(<0.001)。还观察到Mallampatti和Friedman分类评分显著下降(分别为=0.001和<0.001)。无需麻醉,也未观察到不良反应。
非消融性铒激光治疗是一种安全、无痛且可有效减少打鼾的治疗选择,患者接受度良好。然而,需要进一步进行更长随访期的对照研究。铒激光、打鼾、睡眠障碍、爱泼华嗜睡量表、OHIP - 14 。